Active, not recruiting
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
NCT06040099
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Research Site Aurora, Colorado, United States
- Research Site Gainesville, Florida, United States
- Research Site Orlando, Florida, United States
- Research Site Atlanta, Georgia, United States